Vinay Prasad's interim replacement has concerns about same drug that drove him out. NIH director says employee critics ...

The new rule comes after a public advisory committee meeting in May that reviewed data showing risks for patients who use opioids over long periods. Those risks include misuse, addiction and overdoses ...

Other states have enacted similar laws that would strip artificial dyes from school meals, but West Virginia's action is the ...

The FDA is mandating new labeling for opioids to better inform patients and healthcare providers about the risks of addiction ...

The FDA has denied that it plans to combine the Center for Drug Evaluation and Research and Center for Biologics Evaluation ...

A panel organized by the FDA cast doubts on the safety of antidepressants during pregnancy — drawing ire from doctors who say SSRIs are a crucial treatment option for women with perinatal depression.

The FDA has released a report to educate the public regarding the dangers of 7-OH and its distinction from the kratom plant ...

FDA maintains deregulatory approach as consumers use apps to identify harmful ingredients in beauty products while advocacy ...

According to a Department of Health and Human Services spokesperson, he resigned to “spend more time with his family.” ...

Commissioner Marty Makary again promoted a conspiracy theory about the origins of the COVID-19 pandemic on Wednesday, ...

U.S. President Donald Trump reportedly ordered the removal of Vinay Prasad as director of the FDA’s Center for Biologics ...

Marty Makary has been the commissioner of the FDA for more than 100 days, much of which he has spent doing what he calls a “listening tour ” in six cities and asking FDA staff what they’ve ...